Alzheimer's disease has a biologically based definition, according to criteria developed by an Alzheimer's Association workgroup. The new criteria include biomarker classifications and a revised ...

Today, Prof. Howard Feldman presented revised diagnostic criteria for Alzheimer's disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference in Madrid on behalf of the International ...

In October, Caring—an organization supporting caregivers of people with dementia—released its rankings of the most dementia-friendly states. Such reports are issued occasionally by various entities, ...

Alzheimer’s disease (AD) is a progressive, neurodegenerative disease characterized by accumulation of beta-amyloid in extracellular plaques and tau protein in intracellular neurofibrillary tangles ...

Every few weeks, a 65-year-old man named Rick drives an hour and a half from his home in New Hampshire to Brigham and Women’s Hospital in Boston, where a nurse inserts a needle in his arm and a clear ...

Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer’s disease have not been extensively investigated in longitudinal studies. We conducted a ...

Nearly 7 million Americans currently live with Alzheimer's, and by 2060, experts say that number could be as high as 14 million. Scientists are trying to find out why one man has been able to stave ...